PATH MER Indicators, published by PATH. This is not an authorized publication; it is the continuous build for version 0.1.0). This version is based on the current content of https://github.com/PATH-Global-Health/MERindicators and changes regularly. See the Directory of published versions
CodeSystem: CIEL
(Experimental)
| Official URL: https://openconceptlab.org/orgs/CIEL/sources/CIEL
|
Version:
0.1.0
|
|
Draft
as of 2023-10-19
|
Computable Name: CIEL |
Columbia International eHealth Laboratory (CIEL)
This Code system is referenced in the content logical definition of the following value sets:
This case-insensitive code system https://openconceptlab.org/orgs/CIEL/sources/CIEL defines the following codes:
| Code | Display |
| 1065 | YES |
| 1066 | NO |
| 1067 | Unknown |
| 1434 | Currently pregnant |
| 138405 | Human immunodeficiency virus (HIV) disease |
| 160119 | CURRENTLY TAKING ARV |
| 116128 | Malaria |
| 160540 | Method of enrollment |
| 160542 | Outpatient department |
| 1193 | CURRENT DRUGS USED |
| 5096 | RETURN VISIT DATE |
| 164384AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA | Treatment end date |
| 164384 | Treatment end date |
| 160104 | Efavirenz / Lamivudine / Stavudine |
| 160105 | Efavirenz / Stavudine / Zidovudine |
| 160124 | Efavirenz / Lamivudine / Zidovudine |
| 161361 | efavirenz / lamivudine / tenofovir disoproxil |
| 161363 | lamivudine / stavudine |
| 161364 | Lamivudine / tenofovir disoproxil |
| 1652 | Lamivudine / nevirapine / zidovudine |
| 5424 | Other antiretroviral drug |
| 5811 | Unknown antiretroviral drug |
| 630 | Lamivudine / zidovudine |
| 103166 | Abacavir / lamivudine |
| 70056 | Abacavir |
| 71647 | Atazanavir |
| 74807 | Didanosine |
| 75523 | Efavirenz |
| 75628 | Efavirenz |
| 77995 | Indinavir |
| 78643 | Lamivudine |
| 79040 | Lopinavir |
| 792 | Lamivudine / nevirapine / stavudine |
| 794 | Lopinavir / ritonavir |
| 80487 | Nelfinavir |
| 80586 | Nevirapine |
| 83412 | Ritonavir |
| 84309 | Stavudine |
| 84795 | Tenofovir |
| 86663 | Zidovudine |
| 01234 | Tenofovir / Lamivudine / Dolutegravir |